SERPINE2 and breast carcinoma: Analysis of serpinE2 in the Cancer Genome Atlas (TCGA) breast carcinoma dataset using cBioPortal [33, 34], revealed that only limited numbers of tumors harbor genetic alterations (6/960), however, 61 show elevated serpinE2 mRNA levels (Fc >1.5).